Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07602842
PHASE1/PHASE2

A Study of IDP-001 in Advanced or Metastatic Solid Tumors

Sponsor: InduPro, Inc.

View on ClinicalTrials.gov

Summary

This clinical study is to evaluate the safety, tolerability, pharmacokinetics (PK), and preliminary antitumor activity of IDP-001 in participants with advanced or metastatic squamous and non-squamous NSCLC and other squamous cell solid tumors (for example, head and neck, esophageal, cervical, cutaneous).

Official title: A Phase 1/2 Open-label Study of IDP-001 in Advanced or Metastatic Squamous Cell Lung Cancer and Other Solid Tumors

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

132

Start Date

2026-06

Completion Date

2028-12

Last Updated

2026-07-27

Healthy Volunteers

No

Interventions

DRUG

IDP-001

IV infusion

Locations (4)

START Los Angeles

Los Angeles, California, United States

Hackensack Meridian - John Theurer Cancer Center

Edison, New Jersey, United States

START New York Long Island

Lake Success, New York, United States

START Dallas Forth Worth

Fort Worth, Texas, United States